Titlesort descending Credit Type Event date Cost
Treating Cancer with Bispecific Antibodies: Current Status and Future Directions
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
 Enduring $0.00
Unveiling Progress: Advancements in Treatment and Genomics of Metastatic Breast Cancer
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
 Enduring $0.00
Updates in Lymphoma
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Updates in Lymphoma 2024
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Updates in Management of Advanced Renal Cell Carcinoma: Making Sense of the Menu
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Urgent/Emergent Care Issues in Oncology
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Virtual Practice Managing Immune-Related Adverse Events (irAEs) in Simulated Scenarios
    • 0.50 AMA PRA Category 1 Credit™
 Enduring $0.00
What’s on the Pipeline? A Look into Clinical Research for the APP
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
 Enduring $0.00

Pages